The good and the bad sides of immunotherapy

The Nobel Prize for medicine and physiology was awarded last Monday to Drs. James Allison and Tasuku Honjo for their discoveries which led to the development of immunotherapy, a new anticancer strategy based on the destruction of tumors by stimulation of the immune system. Let’s take a look at the good and the less-good sides of this new class of therapeutic agents. Download the column

9-Oct-2018 |

Share this content!

Recent Articles

Column Archives

Column Keywords